https://www.selleckchem.com/pr....oducts/derazantinib.
ARS-CoV-2 infection. This study investigated the first confirmed case of COVID-19 with concomitant GBS in Colombia. In patients with GBS, several viral and bacterial pathogens have been found in case-control studies but the factors that induce the immune-mediated destruction of the nerve tissues have not been determined. Further studies are needed to determine the possible association between COVID-19 exposure and GBS. The recreational drugs cannabis and nitrous oxide (N O) are known for pro-atherogenic effects and are associated w
Like
Comment
Share
